简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2023-05-04 16:47 Novaliq Announces Presentation of New Scientific Data on CyclASol® 0.1% (Cyclosporine Ophthalmic Solution) at the American Society of Cataract and Refractive Surgery Annual Meeting
2023-05-04 15:56 SPEVIGO® granted Breakthrough Therapy Designation in the U.S. for the prevention of generalized pustular psoriasis flares
2023-04-27 10:39 Alentis Therapeutics Reports Positive Topline Results From Phase 1 Multiple-ascending Dose Cohorts Study
2023-04-25 16:32 Dai Nippon Printing and SCIVAX Enter into Capital and Operational Alliance in Foundry Business for Mass-production of Nanoimprinted Products
2023-04-21 08:58 Data Presented at AACR 2023 Highlights Exscientia’s Clinical and Preclinical Development
2023-04-20 12:23 PCI Pharma Services Announces New Sterile Fill-Finish Capabilities Now Available in Melbourne and San Diego
2023-04-19 13:18 Augmented Reality: Patient Experience Trumps Misconceptions Around Injectables
2023-04-19 11:42 Armis Announces Significant Business Momentum in Healthcare
2023-04-19 09:57 BeautyHealth’s Hydrafacial Opens New Beijing Experience Center, Signaling Continued Investment in High-Growth China Market
2023-04-19 09:42 Armis Identifies the Riskiest Medical and IoT Devices in Clinical Environments
2023-04-19 09:15 KBI Biopharma and Selexis SA Appoint J.D. Mowery as CEO
2023-04-19 08:57 Avistone Announces Interim Data Results on PLB1004 in Patients with EGFR mutant NSCLC Patients at AACR 2023
2023-04-18 17:43 Ferring and BioInnovation Institute enter new strategic collaboration to accelerate innovation in women’s health
2023-04-17 09:30 AristaCare Health Services: The Future of Post-Acute Rehab and Long-Term Care
2023-04-14 16:46 Novaliq Announces Publication of Second Pivotal Phase 3 Trial Data on CyclASol 0.1% (Cyclosporine Ophthalmic Solution) in JAMA Ophthalmology
2023-04-14 11:55 Alentis Therapeutics Closes $105 Million Series C Funding to Advance Transformational Medicines for Claudin-1
2023-04-13 21:04 Berry Consultants Releases FACTS 7 Clinical Trial Simulator
2023-04-12 15:48 Initiation of New Patients on Evobrutinib Paused in the U.S.; Fully Enrolled Phase III Evobrutinib Studies Continue
2023-04-11 08:00 Revolutionizing the Treatment Room: BeautyHealth Launches Connected Hydrafacial Syndeo Device in Europe and Asia
2023-04-07 18:31 Technology Holdings Advises SUAZIO, a Data-Driven Life Sciences and MedTech Strategic Consultancy, on Its Sale to NAMSA

Business Wire Weibo

Press Releases

Latest Releases